Biolase EBITDA 2012-2024 | BIOLQ

Biolase ebitda from 2012 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Biolase Annual EBITDA
(Millions of US $)
2023 $-15
2022 $-24
2021 $-16
2020 $-18
2019 $-14
2018 $-20
2017 $-17
2016 $-14
2015 $-19
2014 $-17
2013 $-10
2012 $-2
2011 $-3
Biolase Quarterly EBITDA
(Millions of US $)
2024-09-30 $0
2024-06-30 $-2
2024-03-31 $-4
2023-12-31 $-4
2023-09-30 $-3
2023-06-30 $-2
2023-03-31 $-5
2022-12-31 $-7
2022-09-30 $-7
2022-06-30 $-5
2022-03-31 $-4
2021-12-31 $-4
2021-09-30 $-2
2021-06-30 $-3
2021-03-31 $-6
2020-12-31 $-5
2020-09-30 $-3
2020-06-30 $-4
2020-03-31 $-5
2019-12-31 $-3
2019-09-30 $-5
2019-06-30 $-3
2019-03-31 $-4
2018-12-31 $-6
2018-09-30 $-4
2018-06-30 $-4
2018-03-31 $-5
2017-12-31 $-4
2017-09-30 $-4
2017-06-30 $-4
2017-03-31 $-4
2016-12-31 $-4
2016-09-30 $-3
2016-06-30 $-3
2016-03-31 $-4
2015-12-31 $-2
2015-09-30 $-5
2015-06-30 $-7
2015-03-31 $-5
2014-12-31 $-4
2014-09-30 $-3
2014-06-30 $-6
2014-03-31 $-4
2013-12-31 $-2
2013-09-30 $-4
2013-06-30 $-2
2013-03-31 $-3
2012-12-31 $1
2012-09-30 $0
2012-06-30 $-2
2012-03-31 $-1
2011-12-31 $-2
2011-09-30 $-1
2011-06-30 $-1
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.049B
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00